Patents by Inventor Morgan JOUANNEAU

Morgan JOUANNEAU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUATERNARY INDAZOLE GLUCOCORTICOID RECEPTOR ANTAGONISTS
    Publication number: 20240150320
    Abstract: The present disclosure provides compounds of Formula I or II. Compounds of Formula I or II may be used in pharmaceutical formulations, and may be used for modulating glucocorticoid receptors.
    Type: Application
    Filed: August 11, 2023
    Publication date: May 9, 2024
    Inventors: Hazel Hunt, Lorna DUFFY, Ian STRUTT, Morgan JOUANNEAU, Thomas HORNSBY, Mark MILLS, Andrew William PHILLIPS, Jon-Paul WARD
  • Quaternary indazole glucocorticoid receptor antagonists
    Patent number: 11787780
    Abstract: The present disclosure provides compounds of Formula I or II. Compounds of Formula I or II may be used in pharmaceutical formulations, and may be used for modulating glucocorticoid receptors.
    Type: Grant
    Filed: June 21, 2021
    Date of Patent: October 17, 2023
    Assignee: Corcept Therapeutics Incorporated
    Inventors: Hazel Hunt, Lorna Duffy, Ian Strutt, Morgan Jouanneau, Thomas Hornsby, Mark Mills, Andrew William Phillips, Jon-Paul Ward
  • BICYCLIC INDAZOLE GLUCOCORTICOID RECEPTOR ANTAGONISTS
    Publication number: 20230242514
    Abstract: The present disclosure provides compounds of Formula I, Ia, Ib, Ib-1, Ib-2, Ic, Ic-1, Id-1, and Id-2. Compounds of Formula I, Ia, Ib, Ib-1, Ib-2, Ic, Ic-1, Id-1, and Id-2 may be used in pharmaceutical formulations, and may be used for modulating glucocorticoid receptors.
    Type: Application
    Filed: December 20, 2022
    Publication date: August 3, 2023
    Inventors: Lorna Duffy, Thomas Hornsby, Morgan Jouanneau, Mark Mills, Andrew William Phillips, Andrew James Smith, Hazel Joan Hunt, Peter Hunt
  • QUATERNARY INDAZOLE GLUCOCORTICOID RECEPTOR ANTAGONISTS
    Publication number: 20230032612
    Abstract: The present disclosure provides compounds of Formula I or II. Compounds of Formula I or II may be used in pharmaceutical formulations, and may be used for modulating glucocorticoid receptors.
    Type: Application
    Filed: June 21, 2021
    Publication date: February 2, 2023
    Inventors: Hazel Hunt, Lorna DUFFY, Ian STRUTT, Morgan JOUANNEAU, Thomas HORNSBY, Mark MILLS, Andrew William PHILLIPS, Jon-Paul WARD